(2008). Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline.
Cita Chicago Style (17a ed.)Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline, 2008.
Cita MLA (8a ed.)Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline, 2008.
Precaución: Estas citas no son 100% exactas.